Form 4: OmniAb CEO Boosts Stake with $1M Share Purchase

OmniAb, Inc. President and CEO Matthew W. Foehr acquired 540,540 shares of common stock in a private placement, increasing his beneficial ownership.

Summary

• Matthew W. Foehr, President and CEO, and a Director of OmniAb, Inc. (OABI), acquired 540,540 shares of the company's common stock.
• The acquisition occurred on August 26, 2025, through a private placement transaction under a Securities Purchase Agreement.
• The shares were purchased at a price of $1.85 per share, which matched the closing price of OmniAb's common stock on August 22, 2025.
• The total value of this acquisition is $999,000 (540,540 shares * $1.85/share).
• Following this transaction, Mr. Foehr beneficially owns a total of 4,341,987 shares of OmniAb, Inc. common stock.
• This total includes 5,211 shares acquired on May 30, 2025, via the Issuer's Employee Stock Purchase Plan (ESPP).
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged investment strategy.

Sentiment

Score: 8

Explanation: The significant insider purchase by the CEO at market price indicates strong management confidence in the company's future, which is generally a very positive signal for investors and suggests a belief in future share price appreciation.

Positives

• The significant purchase of 540,540 shares by the CEO at market price demonstrates strong confidence in the company's future prospects.
• Increased insider ownership aligns management's interests more closely with those of shareholders, signaling a belief in long-term value creation.
• The transaction being executed under a Rule 10b5-1(c) plan suggests a deliberate and pre-planned investment strategy by the executive.

Future Outlook

NA

Industry Context

This insider purchase by the CEO of OmniAb, a company likely operating in the biotechnology or pharmaceutical sector, suggests strong confidence in the company's pipeline, strategic direction, or future growth prospects. Such insider buying is often viewed by investors as a positive signal in growth-oriented industries where future potential is a key valuation driver.

Related Party Transactions

• Matthew W. Foehr, President and CEO, acquired 540,540 shares of common stock in a private placement transaction from the issuer, OmniAb, Inc., at a price of $1.85 per share.

Stakeholder Impact

• Shareholders may view the CEO's increased stake as a strong positive sign of management's commitment and belief in the company's value, potentially boosting investor confidence and share price.
• Employees may perceive increased stability and confidence from leadership, which could positively impact morale and retention.

Key Dates

Recommendation

The substantial purchase of company stock by the President and CEO at market price is a strong indicator of insider confidence. This action suggests that management believes the company's shares are undervalued or that significant positive developments are anticipated. Such a clear alignment of executive interests with shareholder value typically warrants a 'buy' recommendation, as it signals a belief in future appreciation.

Keywords

OmniAb, OABI, Insider Trading, CEO Stock Purchase, Matthew W. Foehr, Private Placement, Share Acquisition, Beneficial Ownership, Form 4, Biotechnology, Pharmaceutical